HGH

£70.00

Out of stock

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH, studied extensively for its effects on body composition, metabolism, and tissue repair. Clinical protocols typically employ subcutaneous administration once daily to mimic physiological GH secretion patterns. This educational protocol presents a gradual titration approach using practical dilution for precise insulin-syringe measurements.

Key benefits

  • Increases in lean body mass and reductions in adipose tissue in clinical studies
  • Enhanced fat oxidation and lipolysis in dose-dependent manner.
  • Sustained improvements in muscle strength and body composition with long-term use in GH-deficient adults.
  • Improved metabolic parameters in appropriate clinical contexts

recommended usage guidelines

Dosage

50IU per vial (adjusted per research protocol)

Administration

Commonly via subcutaneous (SC) or intravenous (IV) injection; intranasal and other methods may be studied

Titration

Protocols vary; often daily or several times per week

Cycle Duration

May include a loading phase followed by a maintenance schedule

Reconstitution

Reconstitute 50IU vial with bacteriostatic water according to study design

Storage

Store lyophilised powder in a cool, dry place. Refrigerate after reconstitution

product contents

1x

HGH 50IU vial

1x

Bacteriostatic water

10x

Insulin needle syringes

10x

Alcohol swabs

Important note: For research use only